Lisa Butler

Geciteerd door

	Alles	Sinds 2020
Citaties	11556	5644
h-index	56	39
i10-index	126	105

1300

650

325

975

200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202554 53 99 136 177 185 211 228 215 240 222 321 400 552 475 527 501 568 603 693 1027 1135 1299 1300 180

Openbare toegang

Alles bekijken

109 artikelen

12 artikelen

beschikbaar

niet beschikbaar

Op basis van financieringsmachtigingen

Medeauteurs

Maggie CenteneraUniversity of AdelaideGeverifieerd e-mailadres voor adelaide.edu.au
Luke A. SelthProfessor at Flinders UniversityGeverifieerd e-mailadres voor flinders.edu.au
Tina Bianco-MiottoUniversity of Adelaide, Waite Research Institute & Robinson Research InstituteGeverifieerd e-mailadres voor adelaide.edu.au
Theresa E HickeyUniversity of AdelaideGeverifieerd e-mailadres voor adelaide.edu.au
Stephen N Birrell MD PhD FRACSHAVAH TherapeuticsGeverifieerd e-mailadres voor havahtx.com
Carmela RicciardelliUniversity of Adelaide, Robinson Research InstituteGeverifieerd e-mailadres voor adelaide.edu.au
Matthew SchiewerKimmel Cancer Center at Thomas Jefferson UniversityGeverifieerd e-mailadres voor jefferson.edu
Zeyad D NassarSchool of Medicine, University of AdelaideGeverifieerd e-mailadres voor adelaide.edu.au
Jonathan M. HarrisProfessor, Queensland University of TechnologyGeverifieerd e-mailadres voor qut.edu.au
Leonard GomellaProfessor of Urology, Thomas Jefferson UniversityGeverifieerd e-mailadres voor jefferson.edu
Ian R D JohnsonTelespazio for European Space AgencyGeverifieerd e-mailadres voor esa.int
Gerhard (Gerry) CoetzeeProfessor Van Andel Research InstituteGeverifieerd e-mailadres voor vai.org
Gail RisbridgerMonash UniversityGeverifieerd e-mailadres voor monash.edu
Carlos Cordon-CardoChair, Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at MountGeverifieerd e-mailadres voor mssm.edu
Aleksandra OchnikUniversity of South AustraliaGeverifieerd e-mailadres voor unisa.edu.au
Karen ChiamCancer Council NSWGeverifieerd e-mailadres voor nswcc.org.au
Andreas EvdokiouGeverifieerd e-mailadres voor adelaide.edu.au
Preethi RavindranathanBaylor Research InstituteGeverifieerd e-mailadres voor bswhealth.org
Rajdeep DasUniversity Hospitals Cleveland Medical CenterGeverifieerd e-mailadres voor uhhospitals.org
Gregory J GoodallProfessor, Centre for Cancer Biology, SA Pathology, and University of South AustraliaGeverifieerd e-mailadres voor unisa.edu.au

Volgen

Lisa Butler

University of Adelaide

Geverifieerd e-mailadres voor adelaide.edu.au - Homepage


Titel Sorteren op citaties Sorteren op jaar Sorteren op titel	Geciteerd door Geciteerd door	Jaar
Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo LM Butler, DB Agus, HI Scher, B Higgins, A Rose, C Cordon-Cardo, ... Cancer research 60 (18), 5165-5170, 2000	834	2000
The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin LM Butler, X Zhou, WS Xu, HI Scher, RA Rifkind, PA Marks, VM Richon Proceedings of the National Academy of Sciences 99 (18), 11700-11705, 2002	663	2002
Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention LM Butler, Y Perone, J Dehairs, LE Lupien, V de Laat, A Talebi, M Loda, ... Advanced drug delivery reviews 159, 245-293, 2020	490	2020
Dual roles of PARP-1 promote cancer growth and progression MJ Schiewer, JF Goodwin, S Han, JC Brenner, MA Augello, JL Dean, ... Cancer discovery 2 (12), 1134-1149, 2012	488	2012
Androgen receptor inhibits estrogen receptor-α activity and is prognostic in breast cancer AA Peters, G Buchanan, C Ricciardelli, T Bianco-Miotto, MM Centenera, ... Cancer research 69 (15), 6131-6140, 2009	474	2009
Targeting the androgen receptor: improving outcomes for castration-resistant prostate cancer HI Scher, G Buchanan, W Gerald, LM Butler, WD Tilley Endocrine-related cancer 11 (3), 459-476, 2004	310	2004
Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancer G Zadra, CF Ribeiro, P Chetta, Y Ho, S Cacciatore, X Gao, S Syamala, ... Proceedings of the National Academy of Sciences 116 (2), 631-640, 2019	260	2019
Therapeutic response to CDK4/6 inhibition in breast cancer defined by ex vivo analyses of human tumors JL Dean, AK McClendon, TE Hickey, LM Butler, WD Tilley, AK Witkiewicz, ... Cell cycle 11 (14), 2756-2761, 2012	256	2012
Tumour fatty acid metabolism in the context of therapy resistance and obesity AJ Hoy, SR Nagarajan, LM Butler Nature Reviews Cancer 21 (12), 753-766, 2021	247	2021
Discovery of circulating microRNAs associated with human prostate cancer using a mouse model of disease LA Selth, S Townley, JL Gillis, AM Ochnik, K Murti, RJ Macfarlane, KN Chi, ... International journal of cancer 131 (3), 652-661, 2012	246	2012
Maximizing the therapeutic potential of HSP90 inhibitors LM Butler, R Ferraldeschi, HK Armstrong, MM Centenera, P Workman Molecular cancer research 13 (11), 1445-1451, 2015	240	2015
Cancer-associated fibroblasts—heroes or villains? KA Gieniec, LM Butler, DL Worthley, SL Woods British journal of cancer 121 (4), 293-302, 2019	224	2019
The histone deacetylase inhibitor, CBHA, inhibits growth of human neuroblastoma xenografts in vivo, alone and synergistically with all-trans retinoic acid DC Coffey, MC Kutko, RD Glick, LM Butler, G Heller, RA Rifkind, PA Marks, ... Cancer research 61 (9), 3591-3594, 2001	209	2001
Minireview: the contribution of different androgen receptor domains to receptor dimerization and signaling MM Centenera, JM Harris, WD Tilley, LM Butler Molecular endocrinology 22 (11), 2373-2382, 2008	199	2008
Global levels of specific histone modifications and an epigenetic gene signature predict prostate cancer progression and development T Bianco-Miotto, K Chiam, G Buchanan, S Jindal, TK Day, M Thomas, ... Cancer epidemiology, biomarkers & prévention 19 (10), 2611-2622, 2010	196	2010
Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylase LM Butler, Y Webb, DB Agus, B Higgins, TR Tolentino, MC Kutko, ... Clinical cancer research 7 (4), 962-970, 2001	179	2001
Peptidomimetic targeting of critical androgen receptor–coregulator interactions in prostate cancer P Ravindranathan, TK Lee, L Yang, MM Centenera, L Butler, WD Tilley, ... Nature communications 4 (1), 1923, 2013	167	2013
Ex vivo culture of human prostate tissue and drug development MM Centenera, GV Raj, KE Knudsen, WD Tilley, LM Butler Nature Reviews Urology 10 (8), 483-487, 2013	157	2013
The diversity and breadth of cancer cell fatty acid metabolism SR Nagarajan, LM Butler, AJ Hoy Cancer & Metabolism 9 (1), 2, 2021	156	2021
Human DECR1 is an androgen-repressed survival factor that regulates PUFA oxidation to protect prostate tumor cells from ferroptosis ZD Nassar, CY Mah, J Dehairs, IJG Burvenich, S Irani, MM Centenera, ... Elife 9, e54166, 2020	148	2020

Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.

Artikelen 1–20

Citaties per jaar

Dubbele citaties

Samengevoegde citaties

Medeauteurs toevoegenMedeauteurs

Volgen

Geciteerd door

Medeauteurs